Answers are grounded in this paper and cite their sources.
Case-control study reports efficacy and safety outcomes of intrabursal doxycycline sclerotherapy in recurrent olecranon bursitis, highlighting an intervention for refractory cases.
This study aimed to determine the efficacy and safety of intrabursal injection of doxycycline sclerotherapy to treat olecranon bursitis (OB) refractory to conservative management.
No takes yet. Share an insight, caveat, or question.
McDermott et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: